Intersect ENT (XENT) Reports In-Line Q1 EPS

Intersect ENT (NASDAQ: XENT) reported Q1 EPS of ($0.29), in-line with the analyst estimate of ($0.29). Revenue for the quarter came in at $16.7 million versus the consensus estimate of $16.92 million.

Intersect ENT reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Intersect ENT (XENT) click here.

You May Also Be Interested In

• O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
• Towne Bank (TOWN) Reports In-Line Q1 EPS
• ChampionX (CHX) Tops Q1 EPS by 8c